Clinical Trials Directory

Trials / Conditions / Endometrial Endometrioid Adenocarcinoma

Endometrial Endometrioid Adenocarcinoma

15 registered clinical trials studyying Endometrial Endometrioid Adenocarcinoma — 5 currently recruiting.

StatusTrialSponsorPhase
WithdrawnVirtual Mental Health Intervention to Address Fear of Progression for Women With High Risk or Stage III-IV Gyn
NCT07226102
City of Hope Medical CenterN/A
Not Yet RecruitingProgestins for the Treatment of Endometrial Cancer or Precancers of the Uterus Before Surgery, The Pro-Window
NCT07436793
New Mexico Cancer Research AlliancePhase 2
RecruitingONC201 and Atezolizumab in Obesity-Driven Endometrial Cancer
NCT05542407
UNC Lineberger Comprehensive Cancer CenterPhase 1
UnknownAMT-151 in Patients With Selected Advanced Solid Tumours
NCT05498597
Multitude Therapeutics Inc.Phase 1
RecruitingTesting the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Se
NCT05256225
National Cancer Institute (NCI)Phase 3
RecruitingTesting Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial
NCT05112601
National Cancer Institute (NCI)Phase 2
Completed[SENTRY] Tailoring Postoperative Management Through Sentinel Lymph Node Biopsy in Low- and Intermediate-Risk E
NCT04972682
Moscow City Oncology Hospital No. 62N/A
Active Not RecruitingTesting the Addition of the Immunotherapy Drug, Pembrolizumab, to the Usual Radiation Treatment for Newly Diag
NCT04214067
National Cancer Institute (NCI)Phase 3
WithdrawnEvaluation of the Efficacy for Sentinel Lymph Node Policy in Intermediate-risk Endometrial Carcinomas
NCT03677024
Fudan UniversityN/A
Active Not RecruitingTesting the Addition of the Immunotherapy Drug Pembrolizumab to the Usual Chemotherapy Treatment (Paclitaxel a
NCT03914612
National Cancer Institute (NCI)Phase 3
CompletedAbemaciclib and Letrozole in Treating Patients With Endometrial Cancer
NCT04049227
Northwestern UniversityEARLY_Phase 1
RecruitingShort Course Vaginal Cuff Brachytherapy in Treating Participants With Stage I-II Endometrial Cancer
NCT03422198
University of UtahPhase 3
CompletedCopanlisib in Treating Patients With Persistent or Recurrent Endometrial Cancer
NCT02728258
NRG OncologyPhase 2
CompletedNab-Paclitaxel and Bevacizumab in Treating Patients With Unresectable Stage IV Melanoma or Gynecological Cance
NCT02020707
Mayo ClinicPhase 1
CompletedSunitinib Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer
NCT00478426
National Cancer Institute (NCI)Phase 2